BR112012011227A2 - theobromine and agent combined with another non-opioid antitussive and its therapeutic use - Google Patents

theobromine and agent combined with another non-opioid antitussive and its therapeutic use

Info

Publication number
BR112012011227A2
BR112012011227A2 BR112012011227A BR112012011227A BR112012011227A2 BR 112012011227 A2 BR112012011227 A2 BR 112012011227A2 BR 112012011227 A BR112012011227 A BR 112012011227A BR 112012011227 A BR112012011227 A BR 112012011227A BR 112012011227 A2 BR112012011227 A2 BR 112012011227A2
Authority
BR
Brazil
Prior art keywords
theobromine
opioid
antitussive
therapeutic use
another non
Prior art date
Application number
BR112012011227A
Other languages
Portuguese (pt)
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012011227(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012011227A2 publication Critical patent/BR112012011227A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

teobromina e agente combinado com outro antitussígeno não opióide e seu uso terapêutico. um agente que compreende teobromina e outro não opióide antitussígeno, para uso simultâneo, sequencial ou separado, em terapias da tosse.theobromine and agent combined with another non-opioid antitussive and its therapeutic use. an agent comprising theobromine and another antitussive non-opioid for simultaneous, sequential or separate use in cough therapies.

BR112012011227A 2009-11-13 2010-11-12 theobromine and agent combined with another non-opioid antitussive and its therapeutic use BR112012011227A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
BR112012011227A2 true BR112012011227A2 (en) 2017-06-13

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012011227A BR112012011227A2 (en) 2009-11-13 2010-11-12 theobromine and agent combined with another non-opioid antitussive and its therapeutic use

Country Status (16)

Country Link
EP (1) EP2498777A2 (en)
JP (2) JP2013510841A (en)
CN (1) CN102753174A (en)
AU (1) AU2010317667B2 (en)
BR (1) BR112012011227A2 (en)
CA (1) CA2780703A1 (en)
CO (1) CO6551744A2 (en)
GB (1) GB0919889D0 (en)
IL (1) IL219768A0 (en)
MX (1) MX2012005532A (en)
NZ (1) NZ599949A (en)
PE (1) PE20130147A1 (en)
RU (1) RU2519086C2 (en)
UA (1) UA108993C2 (en)
WO (1) WO2011058373A2 (en)
ZA (1) ZA201204248B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
WO2017117347A1 (en) * 2015-12-30 2017-07-06 Markovitz M D Paul Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
EP0944604B1 (en) * 1996-11-25 2005-01-12 The Procter & Gamble Company Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
DE602004013011D1 (en) * 2003-05-29 2008-05-21 Unilever Nv HAIR TREATMENT COMPOSITIONS
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080176955A1 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Also Published As

Publication number Publication date
UA108993C2 (en) 2015-07-10
IL219768A0 (en) 2012-07-31
CA2780703A1 (en) 2011-05-19
RU2012124038A (en) 2013-12-20
ZA201204248B (en) 2013-02-27
WO2011058373A3 (en) 2011-07-07
NZ599949A (en) 2013-08-30
RU2519086C2 (en) 2014-06-10
MX2012005532A (en) 2012-09-28
EP2498777A2 (en) 2012-09-19
CO6551744A2 (en) 2012-10-31
JP2016128439A (en) 2016-07-14
AU2010317667A1 (en) 2012-06-07
WO2011058373A2 (en) 2011-05-19
JP2013510841A (en) 2013-03-28
PE20130147A1 (en) 2013-03-13
AU2010317667B2 (en) 2014-05-29
CN102753174A (en) 2012-10-24
JP6118919B2 (en) 2017-04-19
GB0919889D0 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
BR112012011227A2 (en) theobromine and agent combined with another non-opioid antitussive and its therapeutic use
BRPI0914678A8 (en) TOILET DISPENSING DEVICE AND PROCESS FOR DELIVERING A TREATMENT COMPOSITION TO A SANITARY DEVICE
GT201300320A (en) COMBINATION THERAPY INCLUDING A CDK4 / 6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN CANCER TREATMENT.
CL2008002381A1 (en) Immunostimulatory oligonucleotide; pharmaceutical composition comprising it; and its use to treat a disorder or condition in a subject, including cancer.
PA8631801A1 (en) TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES
MX2009010066A (en) Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer.
CL2007000876A1 (en) USE OF AN ANTAGONIST OF THE VASCULAR ENDOTELIAL GROWTH FACTOR (VEGF) IN COMBINATION WITH A SECOND AGENT UNDERSTANDING A MIELOID CELL REDUCING AGENT TO TREAT A RESISTANT TUMOR IN A SUBJECT; AND TUMOR DIAGNOSIS METHOD.
BR112012014159A8 (en) therapeutic combinations of theobromine and an antihistamine
TW200744568A (en) Epinephrine dosing regimens
BRPI1011572A2 (en) Glycosoligosaccharides comprising glycosidic (alpha1-4) and (alpha1-6) bonds, their use, and methods for their supply
CL2007003523A1 (en) COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT
CL2013001324A1 (en) Kit comprising ec145 and one or more additional chemotherapeutic agents; Use to treat cancer.
MX343598B (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy.
BR112012011224A2 (en) theobromine and agent combined with an antitussive opioid and its therapeutic use
BR112012022243A8 (en) Use of a thioxanthone-based autophagy inhibitor and an autophagy-inducing compound for cancer therapy, pharmaceutical composition and pharmaceutical kit
BR112012029844A2 (en) metamorphine use in combination with a glucokinase activator and combinations comprising metamorphine with a glucokinase activator
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
BR112013017953A2 (en) PHARMACEUTICAL COMPOSITION, TOPICAL FORMULATION, METHOD, AND PHOTOSENSITIZING COMPOSITION
ECSP12012132A (en) COMBINATION OF THEOBROMINE WITH A DESCONGESTIVE AND ITS USE FOR THE TOS TREATMENT
AR073180A1 (en) PRODUCTS CONTAINING DERIVATIVES OF AMIDINA WITH CYCLE DEPSIPEPTIDES
DK2050435T3 (en) cough Preparation
CL2010001594A1 (en) Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide.
BR112014030570A2 (en) wild thyme extracts and use of these
CL2011000252A1 (en) Use of estriol to prepare a useful medication in the prevention and / or treatment of urogenital atrophy in women.
ECSP12011969A (en) THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2493 DE 16/10/2018.

B350 Update of information on the portal [chapter 15.35 patent gazette]